Morris Plains, NJ, August 28, 2011 --(PR.com
)-- Skila, a leading provider of fully managed Software-as-a-Service (SaaS) product launch management and key opinion leader (KOL) management solutions to pharmaceutical and medical device companies, announced today that Dr. Richard Nichol, Ph.D. has joined the company’s Board of Directors, effective immediately.
Dr. Nichol brings to Skila more than 40 years of management, global market strategy and corporate governance experience in the pharmaceutical and biotechnology industry. Dr. Nichol has served on six private and public corporate boards, was named a finalist for Entrepreneur of the Year, Orange County, CA in 1990, and was Chairman of the Chief Executive Roundtable, University of California, Irvine, from 1996 to 1997.
“We are excited to have Dr. Nichol join our Board of Directors. He is an excellent addition and I expect he will make an immediate impact on our vision and business initiatives. I am personally looking forward to working closely with him,” said Drew McCartney, Chief Executive Officer of Skila.
Harold Blue, Managing Partner of BelHealth Investment Partners L.P., and Chairman of the Board of Skila, said “We are excited to have Dr. Nichol join our Board of Directors. He brings just what we need - deep pharmaceutical experience and background helping growing companies execute on their business plans. His efforts will immediately accelerate our strategic partnering efforts as well as benefit our existing relationships. As Skila’s lead outside director he will be an important contributor to our Board as we focus on growing Skila."
“In today’s economic climate most companies are looking for quick ROIs when they evaluate technology and Skila clearly delivers those results to the life sciences industry. In my role on the Board of Directors, I look forward to helping the team as Skila continues to grow,” said Dr. Nichol.